EPElwira Przybylik-Mazurek

Elwira Przybylik-Mazurek

*This is an algorithmically generated author record based on publicly available information.

Elwira Przybylik-Mazurek has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors?

    by Anna Sowa-Staszczak, Robert Chrzan, Dorota Pach, Agnieszka Stefańska, Monika Tomaszuk, Monika Buziak-Bereza, Maciej Kołodziej, Elwira Przybylik-Mazurek, Alicja Hubalewska-Dydejczyk


    • 1 January 2006
      • Vol. 63  (8) , 701-5

    [Primary adrenal lymphoma in incidentally discovered adrenal tumour].

    by Elwira Przybylik-Mazurek, Andrzej Darczuk, Bohdan Huszno, Andrzej Budzyński, Kazimierz Rembiasz, Krystyna Gałazka, Wojciech Wierzchowski, Agnieszka Giza, Wojciech Jurczak, Aleksander B Skotnicki, et al.

    The new imaging techniques used during the last several years: ultrasound, computed tomography and magnetic resonance imaging have improved detection of non-functional adrenal tumours s.c. "incidentaloma". Incidence of adrenal incidentaloma is not very low. They are detected in about 0.35-4.36% CT examination. In most of cases incidentaloma are benign and gave no clinical signs; however primary adrenal cortex cancer and metastases of different cancers are not uncommon. The primary adrenal lymphoma is an extremely rare disease. The predominant group of patients are men over 50 years with other manifestations of non Hodgkin lymphoma. Most frequently both adrenal glands are affected and signs of adrenal insufficiency (despite weakness, fever and loss of weight) are present. In our paper we present a case of primary, unilateral lymphoma in a 19 year old women. It was discovered as incidentaloma in ultrasound examination. Hormonal examinations were normal, but the tumour size was indication for surgery treatment. The diagnosis was made by histological examination and adjuvant chemotherapy was administrated.

    • 1 January 2006
      • Vol. 63  (9) , 719-22

    [Autoimmunological and allergic disorders with Hashimoto and Graves disease].

    by Elwira Przybylik-Mazurek, Barbara Kotlinowska, Magdalena Kasztelnik, Agnieszka Stefańska, Bohdan Huszno

    Graves disease and Hashimoto disease are due to inappropriate activation of immunological system and production of the antibodies against thyroid gland. The aim of the study was to estimate potential risk of other autoagressive and allergic disease in patients with Hashimoto or Graves disease. 255 patients with Graves disease (216 females and 39 males) and 69 patients (63 females and 6 males) mean age 53.6 +/- 13.7 years were examined. The control group consists of 200 patients (175 females and 25 males) mean age 61.98 +/- 14.35 years with nodular goitre. There were 74 cases (i.e. 22.8%) of coexisting autoimmunological or allergic disorder among the patients with autoimmunological thyroid disorders (36 patients with Graves disease and 38 patients with Hashimoto disease). There were 20 cases of type 1 diabetes mellitus, 13 cases of bronchial asthma, 16 cases of Addison' disease, 4 cases of rheumatoid arthritis, 1 case of scleroderma, 4 cases of systemic lupus erythematosus, 2 cases of colitis ulcerosa, 2 cases of myasthenia gravis, 6 cases of Addison-Biermer disease, 3 cases of primary biliary cirrhosis and 3 cases of rhinitis allergica. There were 3 cases (1.5%) of additional auto-immunological or allergic disorder among the control subjects--1 case of type 1 diabetes mellitus and 2 cases of bronchial asthma. Because of the higher risk of coexisting auto-immnunologi-cal or allergic disorder, patients with autoimmunological thyroid disorders should be closely controlled.